Nathaniel E. Hubel

GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein.

J. Cyster, N. Parameswaran, L. Maurer, 2020, The Journal of clinical investigation.

GRK 2 suppresses lymphomagenesis by inhibiting the MALT 1 proto-oncoprotein

J. Cyster, Jing Cheng, N. Parameswaran, 2020 .

MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types

Jing Cheng, Kelly M. Bailey, R. Bridwell, 2019, Oncogene.

The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.

Adrian V. Lee, A. Chinnaiyan, D. Rhodes, 2018, Cancer research.

MALT1 is a Targetable Driver of Epithelial-to-Mesenchymal Transition in Claudin-low, Triple-Negative Breast Cancer.

Adrian V. Lee, S. Oesterreich, D. Krappmann, 2021, Molecular cancer research : MCR.